Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)

Clinical trial NCT00844922 · COMPLETED

Trial details

NCT number: NCT00844922
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Depressive Disorders Psychotic Disorders Depression

Start date: 2005-09-01
Primary completion: 2006-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.